Menstrual cycle effects on common medical conditions

Comprehensive Therapy

Volumn 27, Issue 1, 2001, Pages 65-71

  Case, Allison M ^a   Reid, Robert L ^b  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; ANTIEMETIC AGENT; DANAZOL; ERGOTAMINE; ESTROGEN; GESTAGEN; GONADORELIN; INSULIN; LAXATIVE; MEDROXYPROGESTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEX HORMONE; SPASMOLYTIC AGENT;

ARTICLE; ASTHMA; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; EPILEPSY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IRRITABLE COLON; MENSTRUAL CYCLE; MIGRAINE; PREMENSTRUAL SYNDROME; SIDE EFFECT;

ASTHMA; EPILEPSY; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; PREMENSTRUAL SYNDROME;

EID: 0035100572     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-001-0010-8     Document Type: Article

References (79)

1. The influence of menstruation an health and disease
2. Effects of the menstrual cycle on medical disorders
3. The relationship between a mother's menstrual status and her response to illness in her child
4. Neuroendocrine events that regulate the menstrual cycle
5. Use of GnRH agonists for menstrual cycle-related disorders
6. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin
7. Migraine headache: Epidemiologic perspectives
8. Menstrual migraine: Differential diagnosis, evaluation, and treatment
9. Focus on primary diagnosis and management of headache in women
10. Migraine and menstruation: A pilot study
11. Arteriole supply in normal and hyperplastic endometrium
12. Relation of arterioles in the endometrium to headache from oral contraceptives
13. Relation between headache from oral contraceptives and development of endometrial arterioles
14. The role of estradiol withdrawal in the etiology of menstrual migraine
15. The effect of oral contraceptive on migraine
16. Headaches in the first post partum week and their relationship to migraine
17. Characteristics of headache at menopause: A clinico-epidemiologic study
18. Estrogens, progestins, and headache
19. Prevention of menstrual migraine by percutaneous oestradiol
20. Treatment of menstrual migraine by oestradiol implants
21. Estrogen-withdrawal migraine: I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration
22. Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration
23. Efficacy and safety of percutaneous estradiol vs placebo in menstrual migraine
24. Menstruation, sex hormones, and migraine
25. Blood flow and ovarian secretions
26. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy
27. Influence of the menstrual cycle on systemic disease
28. How common is catamenial epilepsy?
29. Catamenial epilepsy: A review
30. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle
31. Hormones and epilepsy
32. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy
33. Seizure frequency and the menstrual cycle: A clinical study
34. Phenytoin levels in catamenial epilepsy
35. Women's issues in epilepsy. Menses, child-bearing and more
36. Effect of norethisterone on seizures associated with menstruation
37. Treatment of menstrual epilepsy with a progesterone-only oral contraceptive
38. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders
39. Effects of menstruation and pregnancy on epilepsy
40. Menstrual cycle and asthma
41. Asthma variation with menstruation
42. Pre-menstrual exacerbations of asthma
43. The effect of menstruation on immediate skin reactions in patients with respiratory allergy
44. Severe premenstrual exacerbations of asthma: Effect of intramuscular progesterone
45. Menstrual asthma: Use of a gonadotropin-releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma
46. Epidemiology of irritable bowel syndrome in the United States
47. Diagnostic evaluation of the irritable bowel syndrome
48. Evidence for exacerbation of irritable bowel syndrome during menses
49. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo controlled study
50. Inhibition of lower esophageal sphincter circular muscle by female sex hormones
51. Gastrointestinal transit: The effect of the menstrual cycle
52. Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women
53. Pattern of gastrointestinal and somatic symptoms across the menstrual cycle
54. Do gastrointestinal symptoms vary with the menstrual cycle?
55. Alterations in glucose metabolism during menstrual cycle in women with IDDM
56. Catamenial insulin reactions treated with a long-acting gonadotropin releasing hormone agonist
57. Menstruation and control of diabetes
58. Insulin resistance
59. Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle
60. Changes in oral glucose tolerance during the menstrual cycle
61. Menstrual cycle and food cravings in young college women
62. Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm
63. Extrapelvic endometriosis
64. Recurring catamenial pneumothorax treated with a GnRH analogue
65. Acute appendicitis risk in various phases of the menstrual cycle
66. The influence of oral contraceptives on the frequency of acute appendicitis in different phases of the menstrual cycle
67. Influence of menstruation on glaucoma
68. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle
69. Erythema multiforme with ulcerative stomatitis at menstruation
70. Premenstrual urticaria and dermatographism
71. Cyclical variation in paroxysmal supraventricular tachycardia in women
72. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone
73. Progesterone sensitivity as a cause of recurrent anaphylaxis
74. Recurrent anaphylaxis in menstruating women: Treatment with a luteinizing hormone-releasing hormone agonist - A preliminary report
75. Acetylcholinesterase activity and menstrual remissions in myasthenia gravis
76. Timing of surgery during menstrual cycle and survival of pre-menopausal women with operable breast cancer
77. The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma